BioPhausia is a Nordic Specialty Pharma company.
 The company provides cost-effective pharmaceuticals and focuses on three fields: generic products, niche products and original drugs.
News
2008-07-01
Notice of Extraordinary general meeting in BioPhausia AB (publ), August 4, 2008
2008-07-01
Rights issue in BioPhausia AB to finance the acquisition of the pharmaceutical products portfolio acquired from AstraZeneca AB

Read all press releases

Share information
BioPhausia is listed on the OMX Nordic exchange Stockholm AB, Small cap

BioPhausia at OMX 
Calendar
Interim report January - June 2008, 22 August 2008
Interim report January - September 2008, 21 November 2008
Year End report January - December 2008, 12 February 2009


Notice of Extraordinary General Meeting August 4, 2008 

Proxy